A股異動 | 江鈴汽車漲5% 上半年淨利同比增長12%
格隆匯7月27日丨江鈴汽車(000550.SZ)漲5.73%,報18.99元,總市值164億元。7月26日,江鈴汽車發佈2022年半年度業績快報,公吿顯示,2022年1-6月營業總收入為14,222,759,384元,比上年同期下滑19.53%;歸屬於上市公司股東的淨利潤為452,381,022元,比上年同期增長11.64%。2022年上半年,公司利潤總額、淨利潤較上年同期分別上漲0.08%和11.64%,主要是由於本期青雲譜工廠土地及地上建築物處置帶來的利潤增加,衝抵了銷量下降、原材料及芯片成本上漲所導致的利潤下降。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.